Live from the NIH registry
Studies recruiting near Charleston right now
Top 25 of 737 recruiting studies, sorted by proximity — each links to its official registry page
Quantitative Cardiac Parametric Mapping
Cardiomyopathy, Myocarditis, Ischemic Heart Disease
N/A
Interventional 240 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Medical University of South Carolina (Adults and Pediatrics) — Charleston, South Carolina (3.5 mi)
· Sponsor: Pierre Fabre Medicament
CARS: Cannabis and Alcohol Reduction Study
Cannabis Use, Alcohol Use, Unspecified
N/A
Interventional 52 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Giselle Sholler
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
Chronic Pancreatitis, Chronic Pain
EARLY/Phase 1
Interventional 48 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
Switch or Quit R01
Cigarette Smoking, Smoking Behaviors
N/A
Interventional 225 participants sought
Medical Univeristy of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Medical University of South Carolina ( Site 0153) — Charleston, South Carolina (3.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charleston, South Carolina (3.5 mi)
· Sponsor: Sameek Roychowdhury
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Charleston, South Carolina (3.5 mi)
· Sponsor: Alnylam Pharmaceuticals
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ralph H Johnson VA Medical Center — Charleston, South Carolina (3.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Alpha 1-Antitrypsin Deficiency
Phase 1, Phase 2
Interventional 106 participants sought
Clinical Study Center — Charleston, South Carolina (3.5 mi)
· Sponsor: Beam Therapeutics Inc.
Optimizing Care for Cancer Survivors With Depression: Project 3
Cancer, Depression
N/A
Interventional 45 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Charleston, SC — Charleston, South Carolina (3.5 mi)
· Sponsor: Mediar Therapeutics
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Charleston, South Carolina (3.5 mi)
· Sponsor: AstraZeneca
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
Bronchiectasis Adult
N/A
Observational 200 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Synchrony-Medical, Ltd
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — Charleston, South Carolina (3.5 mi)
· Sponsor: Normunity AccelCo, Inc.
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
MUSC Shawn Jenkins Children's Hospital - Cardiology — North Charleston, South Carolina (2.6 mi)
· Sponsor: Bayer
Closed-loop rTMS-EEG During Visuomotor Integration.
Visuomotor Skills, Brain Lesion (General)
N/A
Interventional 20 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
Exoskeleton for Balance
Stroke
N/A
Interventional 21 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
Hollings Cancer Center — Charleston, South Carolina (3.5 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Medical University of South Carolina /ID# 251383 — Charleston, South Carolina (3.5 mi)
· Sponsor: AbbVie
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
Traumatic Injury, Technology
N/A
Interventional 300 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: Medical University of South Carolina
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Medical University of South Carolina(MUSC) Health Ashley River Tower — Charleston, South Carolina (3.5 mi)
· Sponsor: Concept Medical Inc.
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Medical University of South Carolina (MUSC) — Charleston, South Carolina (3.5 mi)
· Sponsor: Pfizer
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Medical University of South Carolina — Charleston, South Carolina (3.5 mi)
· Sponsor: NRG Oncology